Table 10. Outcomes of Tenofovir Disoproxil Fumarate matrix effect .
|
Analyte |
Tenofovir Disoproxil Fumarate |
||
|
Analyte MF |
ISTD MF |
IS normalized factor |
|
|
Lot-I |
0.627 |
0.720 |
0.871 |
|
Lot-II |
0.722 |
0.690 |
1.046 |
|
Lot-III |
0.768 |
0.680 |
1.129 |
|
Lot-IV |
0.762 |
0.678 |
1.124 |
|
Lot-V |
0.653 |
0.714 |
0.916 |
|
Lot-VI |
0.691 |
0.691 |
1.000 |
|
Mean |
- |
- |
1.014 |
|
SD% |
- |
- |
0.106 |
|
CV% |
- |
- |
10.49 |
MF: Matrix factor, ISTD: Internal standard, CV: Coefficient of variation, SD: Standard deviation